4.23
price down icon0.94%   -0.04
 
loading

Finanzdaten der Mei Pharma Inc-Aktie (MEIP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Research and Development
19.81%
0.369
0.308 3.163 - -
Costs And Expenses
19.62%
2.774
3.451 8.352 18.98 9.829
Operating Income/Loss
19.62%
-2.774
-3.451 -8.352 -18.98 -9.829
Nonoperating Income/Loss
74.03%
0.201
0.774 0.345 0.574 0.702
Income/Loss From Continuing Operations Before Tax
3.62%
-2.774
-2.677 -8.007 -18.41 -9.829
Income/Loss From Continuing Operations After Tax
3.88%
-2.573
-2.677 -8.007 -18.41 -9.127
Net Income/Loss
3.88%
-2.573
-2.677 -8.007 -18.41 -9.127
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
6.663
6.663 6.663 - 6.663
Diluted Average Shares
0.00%
6.663
6.663 6.663 - 6.663
Basic Earnings Per Share
2.50%
-0.39
-0.40 -1.20 -2.76 -1.37
Diluted Earnings Per Share
2.50%
-0.39
-0.40 -1.20 -2.76 -1.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):